Sint Maartenskliniek
Ubbergen, Netherlands
NCT Number: NCT06214546
Body weight support systems are commonly used for gait training. A new breed of devices for gait training are soft exosuits. To optimize rehabilitation outcomes, it is important to gain deeper insight in the effect of these support systems on gait. The aim of this study is to investigate the effect of a body weight support system and soft exosuit on dynamic balance and knee and hip kinematics during gait in people with incomplete spinal cord injury.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Ubbergen, Netherlands
Rationale: People with incomplete spinal cord injury (iSCI) often experience gait impairments. Body weight support (BWS) systems are commonly used for gait training. Overground BWS systems could have 2 or 3 degrees of freedom (DoF). A decrease in DoF will reduce the demand's on people's balance capacity during walking. A new breed of devices for gait training are soft exosuits. They could deliver support around the knee and the hip joint, which are the main contributors for bodyweight support. Although a BWS system and a soft exosuit provide both support against gravity these systems differ in the approach of delivering this support. To optimize rehabilitation outcomes, it is important to gain deeper insight in the effect of these support systems on gait. In this study a 2-DoF BWS system, the ZeroG, and a soft exosuit, the Myosuit, will be studied.
Objective: Investigate the effect of a BWS system and soft exosuit on dynamic balance and knee and hip kinematics during gait in people with incomplete spinal cord injury.
Study design: Experimental design.
Study population: Fourteen people with subacute or chronic iSCI (at least 2 weeks after injury) will be included. People with iSCI will be included when having an injury level of C or D on the American Spinal Injury Association Impairment Scale.
Intervention: Participants will visit the Sint Maartenskliniek once and perform overground walking trials in a laboratory setting: regular walking, walking with the ZeroG (BWS system) and walking with the Myosuit (soft exosuit). Each condition consists of 6 walking trials over a distance of 12.5 m.
Main study parameters/endpoints: The main study parameter for dynamic balance during gait will be medio-lateral center of mass excursion. The main study parameter for gait kinematics will be maximum extension of the knee in sagittal plane.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants perform 6 overground walking trials (12.5 m) without support system. Participants perform all measurements (regular walking, Myosuit, ZeroG) on one single measurement day.
Participants perform 6 overground walking trials (12.5 m) while wearing the Myosuit. ZeroG and Myosuit intervention will be performed in random order.
Participants perform 6 overground walking trials (12.5 m) while walking in the ZeroG. ZeroG and Myosuit intervention will be performed in random order.
Time frame: At baseline (during regular walking, during walking with the Myosuit, during walking with the ZeroG)
Difference between regular walking, walking with the Myosuit and walking with the ZeroG. Medio-lateral center of mass excursion
Time frame: At baseline (during regular walking, during walking with the Myosuit, during walking with the ZeroG)
Difference between regular walking, walking with the Myosuit and walking with the ZeroG. Maximum extension of the knee in sagittal plane
Time frame: At baseline (during regular walking, during walking with the Myosuit, during walking with the ZeroG)
Difference between regular walking, walking with the Myosuit and walking with the ZeroG.
Time frame: At baseline (during regular walking, during walking with the Myosuit, during walking with the ZeroG)
Difference between regular walking, walking with the Myosuit and walking with the ZeroG. Maximum extension of the hip in sagittal plane
Time frame: At baseline (during regular walking, during walking with the Myosuit, during walking with the ZeroG)
Difference between regular walking, walking with the Myosuit and walking with the ZeroG. Range of motion of the knee in sagittal plane
Time frame: At baseline (during regular walking, during walking with the Myosuit, during walking with the ZeroG)
Difference between regular walking, walking with the Myosuit and walking with the ZeroG. Range of motion of the hip in sagittal plane
Time frame: At baseline (during regular walking, during walking with the Myosuit, during walking with the ZeroG)
Difference between regular walking, walking with the Myosuit and walking with the ZeroG. Trunk inclination angle excursion
Time frame: At baseline (during regular walking, during walking with the Myosuit, during walking with the ZeroG)
Difference between regular walking, walking with the Myosuit and walking with the ZeroG
Time frame: At baseline (during regular walking, during walking with the Myosuit, during walking with the ZeroG)
Difference between regular walking, walking with the Myosuit and walking with the ZeroG
Time frame: At baseline (during regular walking, during walking with the Myosuit, during walking with the ZeroG)
Difference between regular walking, walking with the Myosuit and walking with the Zero.
Time frame: At baseline (during regular walking, during walking with the Myosuit, during walking with the ZeroG)
Difference between regular walking, walking with the Myosuit and walking with the ZeroG
Time frame: Subject enrollment
Descriptive outcome measure
Time frame: Subject enrollment
Descriptive outcome measure
Time frame: Subject enrollment
Descriptive outcome measure. Calculated with weight and height.
Time frame: Subject enrollment
Descriptive outcome measure.
Time frame: Subject enrollment
Descriptive outcome measure. The scale has five classification levels (A-E), ranging from complete loss of neural function (A) in the affected area to completely normal (E).
Time frame: Subject enrollment
Descriptive outcome measure. There are four sections that impact the level of spinal cord injury: cervical, thoracic, lumbar and sacral.
Sint Maartenskliniek
Other
Effect of a Body Weight Support System and a Soft Exosuit on Gait in People With Incomplete Spinal Cord Injury
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04809987
Incomplete Spinal Cord Injury
Valencia, Spain
View Trial DetailsNCT01961557
Brain Damage, Chronic, Brain Diseases
Bethesda, Maryland, United States
View Trial DetailsNCT05491837
Incomplete Spinal Cord Injury
Islamabad, Pakistan
View Trial DetailsNCT05605912
Incomplete Spinal Cord Injury
Ubbergen, Netherlands
View Trial Details